Praxis Precision Medicines Stock Analysis
PRAX Stock | USD 71.14 3.99 5.31% |
Praxis Precision Medicines is overvalued with Real Value of 34.08 and Target Price of 7.08. The main objective of Praxis Precision stock analysis is to determine its intrinsic value, which is an estimate of what Praxis Precision Medicines is worth, separate from its market price. There are two main types of Praxis Precision's stock analysis: fundamental analysis and technical analysis.
The Praxis Precision stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Praxis Precision is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Praxis Stock trading window is adjusted to America/New York timezone.
Praxis |
Praxis Stock Analysis Notes
About 100.0% of the company shares are owned by institutional investors. The book value of Praxis Precision was at this time reported as 21.52. The company has Price/Earnings To Growth (PEG) ratio of 0.03. Praxis Precision Med recorded a loss per share of 9.17. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 29th of November 2023. Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. The company was incorporated in 2015 and is based in Boston, Massachusetts. Praxis Precision operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1 people. To find out more about Praxis Precision Medicines contact Marcio MBA at 617 300 8460 or learn more at https://praxismedicines.com.Praxis Precision Med Investment Alerts
Praxis Precision Med had very high historical volatility over the last 90 days | |
The company reported the previous year's revenue of 2.45 M. Net Loss for the year was (123.28 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Praxis Precision Medicines currently holds about 165.4 M in cash with (111.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.7. | |
Praxis Precision Med has a frail financial position based on the latest SEC disclosures | |
Over 100.0% of the company shares are owned by institutional investors | |
Latest headline from news.google.com: Praxis Precision Medicines, Inc. Shares Sold by Fmr LLC - MarketBeat |
Praxis Precision Med Upcoming and Recent Events
Earnings reports are used by Praxis Precision to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
6th of February 2024 Upcoming Quarterly Report | View | |
9th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
6th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Praxis Largest EPS Surprises
Earnings surprises can significantly impact Praxis Precision's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2023-05-11 | 2023-03-31 | -0.79 | -0.71 | 0.08 | 10 | ||
2023-02-07 | 2022-12-31 | -0.78 | -0.87 | -0.09 | 11 | ||
2023-11-07 | 2023-09-30 | -0.35 | -0.18 | 0.17 | 48 |
Praxis Precision Environmental, Social, and Governance (ESG) Scores
Praxis Precision's ESG score is a quantitative measure that evaluates Praxis Precision's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Praxis Precision's operations that may have significant financial implications and affect Praxis Precision's stock price as well as guide investors towards more socially responsible investments.
Praxis Stock Institutional Investors
Shares | Verition Fund Managegment, Llc | 2024-09-30 | 559.2 K | Hhg Plc | 2024-09-30 | 523.6 K | Franklin Resources Inc | 2024-09-30 | 445.2 K | Geode Capital Management, Llc | 2024-09-30 | 398.8 K | Kingdon Capital Management Llc | 2024-09-30 | 368 K | Velan Capital Investment Management Lp | 2024-09-30 | 350.7 K | 5am Venture Management, Llc | 2024-09-30 | 340 K | Baker Bros Advisors Lp | 2024-09-30 | 323.1 K | Nuveen Asset Management, Llc | 2024-09-30 | 304.8 K | Blackrock Inc | 2024-06-30 | 1.3 M | Perceptive Advisors Llc | 2024-09-30 | 1.2 M |
Praxis Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.4 B.Praxis Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (1.40) | (1.47) | |
Return On Capital Employed | (1.75) | (1.84) | |
Return On Assets | (1.40) | (1.47) | |
Return On Equity | (1.77) | (1.86) |
Management Efficiency
Praxis Precision Med has return on total asset (ROA) of (0.392) % which means that it has lost $0.392 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6434) %, meaning that it created substantial loss on money invested by shareholders. Praxis Precision's management efficiency ratios could be used to measure how well Praxis Precision manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.47 in 2024. Return On Capital Employed is likely to drop to -1.84 in 2024. At this time, Praxis Precision's Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 108.3 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 3 M in 2024.Last Reported | Projected for Next Year | ||
Book Value Per Share | 10.57 | 10.04 | |
Tangible Book Value Per Share | 10.57 | 10.04 | |
Enterprise Value Over EBITDA | (0.54) | (0.57) | |
Price Book Value Ratio | 2.11 | 1.62 | |
Enterprise Value Multiple | (0.54) | (0.57) | |
Price Fair Value | 2.11 | 1.62 | |
Enterprise Value | 68.1 M | 116.3 M |
Evaluating the management effectiveness of Praxis Precision allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Praxis Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Operating Margin (188.20) | Beta 2.687 | Return On Assets (0.39) | Return On Equity (0.64) |
Technical Drivers
As of the 12th of December 2024, Praxis Precision holds the Coefficient Of Variation of 889.36, risk adjusted performance of 0.0893, and Semi Deviation of 3.13. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Praxis Precision, as well as the relationship between them.Praxis Precision Med Price Movement Analysis
The output start index for this execution was fourty-one with a total number of output elements of twenty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Praxis Precision middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Praxis Precision Med. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Praxis Precision Med Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Praxis Precision insiders, such as employees or executives, is commonly permitted as long as it does not rely on Praxis Precision's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Praxis Precision insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Praxis Precision Outstanding Bonds
Praxis Precision issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Praxis Precision Med uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Praxis bonds can be classified according to their maturity, which is the date when Praxis Precision Medicines has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
PRAXAIR INC 355 Corp BondUS74005PBD50 | View | |
US74005PBT03 Corp BondUS74005PBT03 | View | |
PRAXAIR INC 32 Corp BondUS74005PBQ63 | View | |
US74005PBS20 Corp BondUS74005PBS20 | View | |
PRAXAIR INC 265 Corp BondUS74005PBN33 | View |
Praxis Precision Predictive Daily Indicators
Praxis Precision intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Praxis Precision stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Daily Balance Of Power | (9,223,372,036,855) | |||
Rate Of Daily Change | 0.95 | |||
Day Median Price | 71.14 | |||
Day Typical Price | 71.14 | |||
Price Action Indicator | (1.99) | |||
Period Momentum Indicator | (3.99) |
Praxis Precision Corporate Filings
F4 | 19th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 15th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
13A | 8th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
8K | 6th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 4th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
13A | 22nd of October 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Praxis Precision Forecast Models
Praxis Precision's time-series forecasting models are one of many Praxis Precision's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Praxis Precision's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Praxis Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Praxis Precision prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Praxis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Praxis Precision. By using and applying Praxis Stock analysis, traders can create a robust methodology for identifying Praxis entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (45.34) | (47.61) | |
Operating Profit Margin | (46.48) | (48.80) | |
Net Loss | (45.34) | (47.61) |
Current Praxis Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Praxis analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Praxis analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
7.08 | Strong Buy | 10 | Odds |
Most Praxis analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Praxis stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Praxis Precision Med, talking to its executives and customers, or listening to Praxis conference calls.
Praxis Stock Analysis Indicators
Praxis Precision Medicines stock analysis indicators help investors evaluate how Praxis Precision stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Praxis Precision shares will generate the highest return on investment. By understating and applying Praxis Precision stock analysis, traders can identify Praxis Precision position entry and exit signals to maximize returns.
Begin Period Cash Flow | 62 M | |
Common Stock Shares Outstanding | 6.6 M | |
Total Stockholder Equity | 69.7 M | |
Property Plant And Equipment Net | 2.7 M | |
Cash And Short Term Investments | 81.3 M | |
Cash | 81.3 M | |
Accounts Payable | 5.8 M | |
Net Debt | -78.8 M | |
50 Day M A | 71.728 | |
Total Current Liabilities | 15.7 M | |
Other Operating Expenses | 128.8 M | |
Non Current Assets Total | 3.1 M | |
Non Currrent Assets Other | 416 K | |
Stock Based Compensation | 24.9 M |
Additional Tools for Praxis Stock Analysis
When running Praxis Precision's price analysis, check to measure Praxis Precision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Praxis Precision is operating at the current time. Most of Praxis Precision's value examination focuses on studying past and present price action to predict the probability of Praxis Precision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Praxis Precision's price. Additionally, you may evaluate how the addition of Praxis Precision to your portfolios can decrease your overall portfolio volatility.